Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Reexamination Certificate
2007-06-05
2007-06-05
Jones, Dameron L. (Department: 1618)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
C424S009361, C424S009363, C424S009365, C424S001650, C424S009400, C424S001110
Reexamination Certificate
active
10957628
ABSTRACT:
The invention relates to new, monomeric, perfluoroalkyl-substituted metal complexes, processes for their production, and their use in diagnosis and therapy.The compounds according to the invention are suitable especially as in vivo contrast media in nuclear spin tomography (MRT). They can preferably be used as blood-pool agents and as lymphographic agents.
REFERENCES:
patent: 4859584 (1989-08-01), Horan et al.
patent: 5248498 (1993-09-01), Neumann et al.
patent: 5302370 (1994-04-01), Neumeier et al.
patent: 5401493 (1995-03-01), Lohrmann et al.
patent: 5536491 (1996-07-01), Asai et al.
patent: 5672334 (1997-09-01), Ranney
patent: 5690909 (1997-11-01), Platzek et al.
patent: 6019959 (2000-02-01), Platzek et al.
patent: 6447749 (2002-09-01), Licha et al.
patent: 6461587 (2002-10-01), Platzek et al.
patent: 6468502 (2002-10-01), Platzek et al.
patent: 6641797 (2003-11-01), Platzek et al.
patent: 6676928 (2004-01-01), Platzek et al.
patent: 6818203 (2004-11-01), Platzek et al.
patent: 6916461 (2005-07-01), Platzek et al.
patent: 43 17 588 (1994-12-01), None
patent: 0 266 195 (1987-10-01), None
patent: 0 266 196 (1987-10-01), None
patent: 0 592 306 (1994-04-01), None
Gong et al.,Magn. Reson Imaging, vol. 9, No. 1 (1991) pp. 101-106: “Paramater Optimization and Calibration of Fluorine-19 Magnetic Resonance Imaging at 1.5 Tesla”.
Lee et al.,J. Magn. Reson Imaging, vol. 4, No. 4 (1994), pp. 609-613: “In Vivo Fluorine-19 MR Imaging: Relaxation Enhancement with Gd-DTPA”.
Ratner et al.,Invest. Radiol., vol. 24, No. 3 (1989), pp. 224-227: “Fluorine-19 Relaxation Rate Enhancement and Frequency Shift with Gadolinium-DTPA”.
Thomas et al.,J. Magn. Reson Imaging, vol. 4, No. 4 (1994), pp. 631-635: “Evaluation of the Influence of the Aqueous Phase Bioconstituent Environment on the F-19 T1 of Perfluorocarbon Blood Substitute Emulsions”.
International Search Report, Norwegian, Nov. 14, 2001.
Ebert Wolfgang
Frenzel Thomas
Misselwitz Bernd
Niedballa Ulrich
Platzek Johannes
Jones Dameron L.
Millen White Zelano & Branigan P.C.
Shering aG
LandOfFree
Metal complexes that contain perfluoroalkyl, process for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metal complexes that contain perfluoroalkyl, process for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metal complexes that contain perfluoroalkyl, process for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3887186